Cargando…

Zinc Status Alters Alzheimer's Disease Progression through NLRP3-Dependent Inflammation

Alzheimer's disease is a devastating neurodegenerative disease with a dramatically increasing prevalence and no disease-modifying treatment. Inflammatory lifestyle factors increase the risk of developing Alzheimer's disease. Zinc deficiency is the most prevalent malnutrition in the world a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivers-Auty, Jack, Tapia, Victor S., White, Claire S., Daniels, Michael J.D., Drinkall, Samuel, Kennedy, Paul T., Spence, Harry G., Yu, Shi, Green, Jack P., Hoyle, Christopher, Cook, James, Bradley, Amy, Mather, Alison E., Peters, Ruth, Tzeng, Te-Chen, Gordon, Margaret J., Beattie, John H., Brough, David, Lawrence, Catherine B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Neuroscience 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018890/ https://www.ncbi.nlm.nih.gov/pubmed/33597269 http://dx.doi.org/10.1523/JNEUROSCI.1980-20.2020

Ejemplares similares

Anti-inflammatories in Alzheimer’s disease—potential therapy or spurious correlate?
por: Rivers-Auty, Jack, et al.
Publicado: (2020)

Salmonella typhimurium-induced IL-1 release from primary human monocytes requires NLRP3 and can occur in the absence of pyroptosis
por: Diamond, Catherine E., et al.
Publicado: (2017)

Hallmarks of NLRP3 inflammasome activation are observed in organotypic hippocampal slice culture
por: Hoyle, Christopher, et al.
Publicado: (2020)

Redefining the ancestral origins of the interleukin-1 superfamily
por: Rivers-Auty, Jack, et al.
Publicado: (2018)

Itaconate and fumarate derivatives inhibit priming and activation of the canonical NLRP3 inflammasome in macrophages
por: Hoyle, Christopher, et al.
Publicado: (2022)

The three cytokines IL-1β, IL-18, and IL-1α share related but distinct secretory routes
por: Tapia, Victor S., et al.
Publicado: (2019)

Boron-Based Inhibitors of the NLRP3 Inflammasome
por: Baldwin, Alex G., et al.
Publicado: (2017)

Mechanisms of NLRP3 priming in inflammaging and age related diseases
por: Gritsenko, Anna, et al.
Publicado: (2020)

The two pore potassium channel THIK‐1 regulates NLRP3 inflammasome activation
por: Drinkall, Samuel, et al.
Publicado: (2022)

Inhibition of the NLRP3 inflammasome by HSP90 inhibitors
por: Nizami, Sohaib, et al.
Publicado: (2020)

Bafilomycin A1 enhances NLRP3 inflammasome activation in human monocytes independent of lysosomal acidification
por: Yu, Shi, et al.
Publicado: (2020)

Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models
por: Daniels, Michael J. D., et al.
Publicado: (2016)

The NLRP3–inflammasome as a sensor of organelle dysfunction
por: Seoane, Paula I., et al.
Publicado: (2020)

USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation
por: Palazón‐Riquelme, Pablo, et al.
Publicado: (2018)

LRRC8A is essential for hypotonicity-, but not for DAMP-induced NLRP3 inflammasome activation
por: Green, Jack P, et al.
Publicado: (2020)

Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer’s Disease
por: Martins, Isaura V.A., et al.
Publicado: (2016)

Design, Synthesis and Evaluation of Oxazaborine Inhibitors of the NLRP3 Inflammasome
por: Baldwin, Alex G., et al.
Publicado: (2018)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

Selective inhibition of the K(+) efflux sensitive NLRP3 pathway by Cl(−) channel modulation
por: Swanton, Tessa, et al.
Publicado: (2020)

Evolutionary analyses of the gasdermin family suggest conserved roles in infection response despite loss of pore-forming functionality
por: Angosto-Bazarra, Diego, et al.
Publicado: (2022)

Pentraxin 3 promotes long-term cerebral blood flow recovery, angiogenesis, and neuronal survival after stroke
por: Rajkovic, Ivana, et al.
Publicado: (2018)

Extent of Ischemic Brain Injury After Thrombotic Stroke Is Independent of the NLRP3 (NACHT, LRR and PYD Domains-Containing Protein 3) Inflammasome
por: Lemarchand, Eloise, et al.
Publicado: (2019)

Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer’s Disease
por: Hadjidemetriou, Marilena, et al.
Publicado: (2021)

Sphingosine regulates the NLRP3-inflammasome and IL-1β release from macrophages
por: Luheshi, Nadia M, et al.
Publicado: (2012)

Dynamic interactions and intracellular fate of label-free, thin graphene oxide sheets within mammalian cells: role of lateral sheet size
por: Chen, Yingxian, et al.
Publicado: (2021)

Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasome
por: Ossola, Bernardino, et al.
Publicado: (2023)

Pannexin-1-dependent caspase-1 activation and secretion of IL-1β is regulated by zinc
por: Brough, David, et al.
Publicado: (2009)

Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro
por: Gritsenko, Anna, et al.
Publicado: (2020)

NLRP3-Inflammasome Activating DAMPs Stimulate an Inflammatory Response in Glia in the Absence of Priming Which Contributes to Brain Inflammation after Injury
por: Savage, Catherine Diane, et al.
Publicado: (2012)

Corrigendum: Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro
por: Gritsenko, Anna, et al.
Publicado: (2021)

Using zebrafish larval models to study brain injury, locomotor and neuroinflammatory outcomes following intracerebral haemorrhage
por: Crilly, Siobhan, et al.
Publicado: (2018)

Post-transcriptional control of NLRP3 inflammasome activation in colonic macrophages
por: Filardy, Alessandra A., et al.
Publicado: (2015)

LRRC8A is dispensable for a variety of microglial functions and response to acute stroke
por: Cook, James R., et al.
Publicado: (2022)

Stroke Induces Prolonged Changes in Lipid Metabolism, the Liver and Body Composition in Mice
por: Haley, Michael J., et al.
Publicado: (2019)

Unconventional Pathways of Secretion Contribute to Inflammation
por: Daniels, Michael J. D., et al.
Publicado: (2017)

Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy
por: Kuo, Charisse Y-J., et al.
Publicado: (2022)

NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice
por: Heneka, Michael T., et al.
Publicado: (2012)

PKC/ROS-Mediated NLRP3 Inflammasome Activation Is Attenuated by Leishmania Zinc-Metalloprotease during Infection
por: Shio, Marina Tiemi, et al.
Publicado: (2015)

Zinc inhibits high glucose-induced NLRP3 inflammasome activation in human peritoneal mesothelial cells
por: Fan, Yi, et al.
Publicado: (2017)

Severe COVID-19: NLRP3 Inflammasome Dysregulated
por: van den Berg, Daan F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ualb8du3sn2d6rctfdigl7ra0l